itching. Irritant contact dermatitis, unspecified cause
Conditions
Interventions
Intervention 1: First Group:.5 ml of sterile normal saline is injected subcutaneously in the anterior forearm and after 5 minute with lidocaine.5% and pethedine from the fourth and fifth vertebrae o
Prevention
Treatment - Drugs
First Group:.5 ml of sterile normal saline is injected subcutaneously in the anterior forearm and after 5 minute with lidocaine.5% and pethedine from the fourth and fifth vertebrae of lumbar space
Second group: 01.% mg per kg body weight naloxone that volume has been to.5 ml is injected subcutaneously in the anterior forearm andFirst Group:.5 ml of sterile normal saline is injected subcutaneo
Third group:01.% mg per kg body weight naloxone that volume has been to.5 ml is injected subcutaneously in the anterior forearm and after 5 minute with lidocaine half a percent and pethedine plus 0.1
Sponsors
Vice chancellor for research of Shahrekord University of Medical Science
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients condidate spinal anesthesia using exclusion criteria: the creation of any side effects of naloxone any cardiovascular disease; Addiction to opioids
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Itching. Timepoint: after surgery. Method of measurement: checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Abedinzadeh
Shahrekord University Of Medical Sciences
Outcome results
None listed